Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Genomic Health

Start price
Target price
Perf. (%)
€17.56
13.04.11
€19.00
13.05.11
6.92%
13.05.11

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.70
20.02.11
€61.00
11.05.11
6.70%
11.05.11

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.70
20.02.11
€61.00
11.05.11
6.70%
11.05.11

buy
Merck KGaA

Start price
Target price
Perf. (%)
€31.14
29.09.10
€34.50
29.03.11
1.54%
29.03.11

buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€30.55
10.02.11
€35.00
23.02.11
6.07%
23.02.11

MorphoSys AG

Start price
Target price
Perf. (%)
€15.02
13.07.10
€13.52
13.01.11
35.12%
13.01.11

MorphoSys AG

Start price
Target price
Perf. (%)
€15.02
13.07.10
€13.52
13.01.11
35.12%
13.01.11

Stratec SE

Start price
Target price
Perf. (%)
€25.74
08.06.10
€23.16
08.12.10
16.55%
08.12.10

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€64.93
07.10.10
€73.00
08.11.10
-10.15%
08.11.10

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
buy
Evotec SE

Start price
Target price
Perf. (%)
€2.28
11.10.10
€2.90
29.10.10
5.62%
29.10.10

Top 10 in its market
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.54
21.06.10
€53.60
17.09.10
5.22%
17.09.10

buy
Bayer AG

Start price
Target price
Perf. (%)
€48.54
21.06.10
€53.60
17.09.10
5.22%
17.09.10

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€62.25
14.08.10
€67.00
24.08.10
-6.27%
24.08.10

buy
Arqule Inc.

Start price
Target price
Perf. (%)
€4.51
04.04.10
€5.00
28.05.10
5.74%
28.05.10

QIAGEN NV

Start price
Target price
Perf. (%)
€15.44
19.11.09
€13.90
18.05.10
15.06%
18.05.10

QIAGEN NV

Start price
Target price
Perf. (%)
€15.44
19.11.09
€13.90
18.05.10
15.06%
18.05.10

buy
Stratec SE

Start price
Target price
Perf. (%)
€25.29
24.03.10
€30.00
03.05.10
21.75%
03.05.10

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€16.41
07.01.10
€18.17
14.04.10
10.09%
14.04.10

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€16.41
07.01.10
€18.17
14.04.10
10.09%
14.04.10

Stratec SE

Start price
Target price
Perf. (%)
€19.30
17.08.09
€17.37
17.02.10
34.64%
17.02.10

Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€5.35
26.01.10
€4.25
08.02.10
-7.44%
08.02.10